[go: up one dir, main page]

YU45095A - Derivati benzimidazola, postupci za njihovo prirpremanje i primena tih derivata u medicinskoj terapiji, naročito za lečenje ili sprečavanje virusnih infekcija - Google Patents

Derivati benzimidazola, postupci za njihovo prirpremanje i primena tih derivata u medicinskoj terapiji, naročito za lečenje ili sprečavanje virusnih infekcija

Info

Publication number
YU45095A
YU45095A YU45095A YU45095A YU45095A YU 45095 A YU45095 A YU 45095A YU 45095 A YU45095 A YU 45095A YU 45095 A YU45095 A YU 45095A YU 45095 A YU45095 A YU 45095A
Authority
YU
Yugoslavia
Prior art keywords
alkyl
derivatives
prevention
preparation
viral infections
Prior art date
Application number
YU45095A
Other languages
English (en)
Other versions
YU49443B (sh
Inventor
Stanley Dawes Chamberlain
Georg Walter Koszalka
Original Assignee
The Wellcome Foundation Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Wellcome Foundation Limited filed Critical The Wellcome Foundation Limited
Publication of YU45095A publication Critical patent/YU45095A/sh
Publication of YU49443B publication Critical patent/YU49443B/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30—Nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/052—Imidazole radicals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

Pronalazak se odnosi na derivate benzimidazola formule (I): gde R predstavlja vodonik, atom halogena, ili -NR1R2, gde se R1 i R2, koji mogu biti isti ili različiti, biraju nezavisno od vodonika, C1-6 alkila, cijano C1-6 alkila, hidroksi C1-6 alkila, halo C1-6 alkila, C3-7 cikloalkila, C1-6 alkil C3-7 cikloalkila, C2-6 alkenila, C3-7 cikloalkil C1-6 alkila, C2-6 alkinila, arila, aril C1-6 alkila, heterocikličnog C1-6 alkila, ili R1 i R2 zajedno sa N atomom na koji su vezani obrazuju 3, 4, 5 ili 6-člani heterociklični prsten, kao i njihovi farmaceutski prihvatljivi derivati, i njihovu primenu u medicinskoj terapiji, posebno za lečenje ili sprečavanje virusnih infekcija kao što su one koje izazivaju herpes virusi. Pronalazak se takođe odnosi na pripremanje derivata benzimidazola i na farmaceutske preparate koji ih sadrže.
YU45095A 1994-07-07 1995-07-06 Derivati benzimidazola, postupci za njihovo pripremanje i primena tih derivata u medicinskoj terapiji, naročito za lečenje ili sprečavanje virusnih infekcija YU49443B (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9413724A GB9413724D0 (en) 1994-07-07 1994-07-07 Therapeutic nucleosides

Publications (2)

Publication Number Publication Date
YU45095A true YU45095A (sh) 1999-03-04
YU49443B YU49443B (sh) 2006-03-03

Family

ID=10757983

Family Applications (1)

Application Number Title Priority Date Filing Date
YU45095A YU49443B (sh) 1994-07-07 1995-07-06 Derivati benzimidazola, postupci za njihovo pripremanje i primena tih derivata u medicinskoj terapiji, naročito za lečenje ili sprečavanje virusnih infekcija

Country Status (44)

Country Link
US (4) US6077832A (sh)
EP (1) EP0769017B1 (sh)
JP (1) JP3225045B2 (sh)
KR (1) KR100376075B1 (sh)
CN (2) CN1052010C (sh)
AP (1) AP736A (sh)
AT (1) ATE193298T1 (sh)
AU (1) AU702248B2 (sh)
BG (1) BG63435B1 (sh)
BR (1) BR9508237A (sh)
CY (1) CY2249B1 (sh)
CZ (1) CZ290800B6 (sh)
DE (1) DE69517172T2 (sh)
DK (1) DK0769017T3 (sh)
EE (1) EE03568B1 (sh)
ES (1) ES2147294T3 (sh)
FI (1) FI117629B (sh)
GB (1) GB9413724D0 (sh)
GE (1) GEP20002298B (sh)
GR (1) GR3033744T3 (sh)
HK (1) HK1003711A1 (sh)
HR (1) HRP950382B1 (sh)
HU (1) HU227679B1 (sh)
IL (1) IL114492A (sh)
IS (1) IS1812B (sh)
MD (1) MD1838G2 (sh)
MX (1) MX9606732A (sh)
MY (1) MY117892A (sh)
NO (1) NO308854B1 (sh)
NZ (1) NZ288722A (sh)
OA (1) OA10339A (sh)
PL (1) PL181136B1 (sh)
PT (1) PT769017E (sh)
RO (1) RO117699B1 (sh)
RU (1) RU2145963C1 (sh)
SA (1) SA95160202B1 (sh)
SK (1) SK282046B6 (sh)
TJ (1) TJ270B (sh)
TR (1) TR199500832A2 (sh)
TW (1) TW418196B (sh)
UA (1) UA66744C2 (sh)
WO (1) WO1996001833A1 (sh)
YU (1) YU49443B (sh)
ZA (1) ZA955644B (sh)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9413724D0 (en) * 1994-07-07 1994-08-24 Wellcome Found Therapeutic nucleosides
ES2186799T3 (es) * 1995-08-18 2003-05-16 Univ Michigan Bencimidazoles sustituidos en 5' utilizados como agentes antivirales.
GB9518465D0 (en) * 1995-09-09 1995-11-08 Smithkline Beecham Seiyaku Kk Pharmaceuticals
GB9600143D0 (en) 1996-01-05 1996-03-06 Wellcome Found Therapeutic compounds
GB9600142D0 (en) * 1996-01-05 1996-03-06 Wellcome Found Chemical compounds
US6214801B1 (en) 1996-01-23 2001-04-10 The Regents Of The University Of Michigan Imidazo[1,2-a]pyridine C-nucleosides as antiviral agents
US6475388B1 (en) 1996-11-13 2002-11-05 Transgenomic, Inc. Method and system for RNA analysis by matched ion polynucleotide chromatography
US6576133B2 (en) 1996-11-13 2003-06-10 Transgenomic, Inc Method and system for RNA analysis by matched ion polynucleotide chromatography
GB2319961A (en) * 1996-12-07 1998-06-10 Glaxo Group Ltd Pharmaceutical composition for treatment of restenosis
DE69819695D1 (en) 1997-02-13 2003-12-18 Glaxo Group Ltd Benzimidazolderivate
IL133285A0 (en) 1997-06-10 2001-04-30 Glaxo Group Ltd Benzimidazole derivatives
JP2001512132A (ja) 1997-07-30 2001-08-21 ザ、リージェンツ、オブ、ザ、ユニバーシティ、オブ、ミシガン 抗ウイルス薬としてのリクソフラノシルベンズイミダゾール
US6258264B1 (en) 1998-04-10 2001-07-10 Transgenomic, Inc. Non-polar media for polynucleotide separations
GB9807355D0 (en) * 1998-04-07 1998-06-03 Glaxo Group Ltd Antiviral compound
GB9807354D0 (en) 1998-04-07 1998-06-03 Glaxo Group Ltd Antiviral compound
US6277830B1 (en) * 1998-10-16 2001-08-21 Schering Corporation 5′-amino acid esters of ribavirin and the use of same to treat hepatitis C with interferon
US6576265B1 (en) 1999-12-22 2003-06-10 Acell, Inc. Tissue regenerative composition, method of making, and method of use thereof
GB0008939D0 (en) * 2000-04-11 2000-05-31 Glaxo Group Ltd Process for preparing substituted benzimidazole compounds
EP1644011A1 (en) 2003-06-25 2006-04-12 Stephen F. Badylak Conditioned matrix compositions for tissue restoration
CA2550441C (en) * 2003-12-26 2012-08-28 Kissei Pharmaceutical Co., Ltd. Benzimidazole derivatives and medical uses thereof
WO2006115137A1 (ja) * 2005-04-22 2006-11-02 Kissei Pharmaceutical Co., Ltd. ２－アミノベンズイミダゾール誘導体及びその医薬用途
EA008737B1 (ru) * 2005-12-07 2007-08-31 Леонид Андреевич Кожемякин Средство для профилактики и лечения конъюнктивитов и кератитов различной этиологии (варианты), способ его применения
US8940707B2 (en) 2010-10-28 2015-01-27 Viropharma Incorporated Maribavir isomers, compositions, methods of making and methods of using
US8541391B2 (en) 2010-10-28 2013-09-24 Viropharma Incorporated Crystalline phases of 5,6-dichloro-2-(isopropylamino)-1-β-L-ribofuranosyl-1H-benzimidazole
US8546344B2 (en) 2010-10-28 2013-10-01 Viropharma Incorporated Crystalline phases of 5,6-dichloro-2-(isopropylamino)-1-β-L-ribofuranosyl)-1H-benzimidazole
WO2012138907A2 (en) * 2011-04-05 2012-10-11 Translational Genomics Research Institute Solid forms of curcumin
WO2014004939A1 (en) 2012-06-29 2014-01-03 The Procter & Gamble Company Textured fibrous webs, apparatus and methods for forming textured fibrous webs
US9650376B2 (en) 2013-03-15 2017-05-16 Knopp Biosciences Llc Imidazo(4,5-B) pyridin-2-yl amides as KV7 channel activators
EP4289822A3 (en) 2014-09-12 2024-01-24 Biohaven Therapeutics Ltd. Benzoimidazol-1,2-yl amides as kv7 channel activators
EP3223816B1 (en) * 2014-11-26 2020-04-22 The J. David Gladstone Institutes Methods for treating a cytomegalovirus infection
RU2629670C2 (ru) * 2016-08-04 2017-08-31 Федеральное государственное бюджетное учреждение науки институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова Российской академии наук (ИБХ РАН) 2-Амино-5,6-дифтор-1-(бета-D-рибофуранозил)-бензимидазол, способ получения и противовирусная активность его в отношении вируса герпеса простого 1-го типа
CN118955401A (zh) 2018-03-19 2024-11-15 诺普生物科学有限责任公司 Kv7通道激活剂组合物和使用方法
CN114096549A (zh) * 2020-06-23 2022-02-25 博美利克斯技术公司 新型苯并咪唑衍生物、其制备方法及其作为抗癌剂或者抗病毒剂的用途
EP4480956A3 (en) 2022-10-12 2025-02-19 Takeda Pharmaceutical Company Limited Viral inhibitors, the synthesis thereof, and intermediates thereto
WO2024103979A1 (zh) * 2022-11-17 2024-05-23 北京凯因科技股份有限公司 一种抑制疱疹病毒的化合物

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3399987A (en) * 1965-08-02 1968-09-03 United States Borax Chem 2-alkylaminobenzimidazoles as herbicides
CH443777A (de) * 1965-08-06 1968-02-15 Agripat Sa Verfahren zum Schützen textiler Keratinfasern vor Insektenfrass und Mittel zur Durchführung dieses Verfahrens
US3655901A (en) * 1970-07-30 1972-04-11 Merck & Co Inc Method of inhibiting the formation of phenylethanalamine-n-methyl transferase with 2-aminobenzimidazoles
DE2130030A1 (de) * 1971-06-18 1972-12-21 Bayer Ag Fungizide und bakterizide Mittel
US4002623A (en) * 1974-08-07 1977-01-11 Pfizer Inc. Anti-inflammatory 1-[3-(dialkylamino)propyl]-2-acylaminobenzimidazoles and 2-acylamino-3-[3-(dialkylamino)-propyl]imidazo[4,5-b]pyridines
FR2549938B1 (fr) * 1983-07-25 1987-08-07 Fonderie Soc Gen De Bruleur a premelange gazeux et chaudiere equipee d'un tel bruleur
FR2551442B1 (fr) * 1983-09-05 1987-04-30 Centre Nat Rech Scient Nouveaux derives furaniques, leur preparation et leur application
EP0304624A3 (de) * 1987-07-29 1989-03-22 F. Hoffmann-La Roche Ag Benzimidazol-2-yl-pyridiniumverbindungen
IT1226100B (it) * 1988-07-07 1990-12-10 Dompe Farmaceutici Spa Derivati benzimidazolici farmacologicamente attivi.
SE9003151D0 (sv) * 1990-10-02 1990-10-02 Medivir Ab Nucleoside derivatives
US5248672A (en) * 1990-11-01 1993-09-28 The Regents Of The University Of Michigan Polysubstituted benzimidazole nucleosides as antiviral agents
WO1992018517A1 (en) * 1991-04-17 1992-10-29 Yale University Method of treating or preventing hepatitis b virus
ZA923640B (en) * 1991-05-21 1993-02-24 Iaf Biochem Int Processes for the diastereoselective synthesis of nucleosides
GB9205071D0 (en) * 1992-03-09 1992-04-22 Wellcome Found Therapeutic nucleosides
AU5447094A (en) * 1992-10-21 1994-05-09 Regents Of The University Of Michigan, The Polysubstituted benzimidazoles as antiviral agents
US5399580A (en) * 1993-03-08 1995-03-21 Burroughs Wellcome Co. Therapeutic nucleosides-uses
GB9413724D0 (en) * 1994-07-07 1994-08-24 Wellcome Found Therapeutic nucleosides
JP6217655B2 (ja) * 2015-01-15 2017-10-25 トヨタ自動車株式会社 電力変換装置

Also Published As

Publication number Publication date
MY117892A (en) 2004-08-30
ES2147294T3 (es) 2000-09-01
TW418196B (en) 2001-01-11
DE69517172T2 (de) 2000-10-19
HRP950382A2 (en) 1997-08-31
WO1996001833A1 (en) 1996-01-25
GB9413724D0 (en) 1994-08-24
IL114492A (en) 2002-05-23
MD1838F2 (en) 2002-01-31
TR199500832A2 (tr) 1996-06-21
CN1236616A (zh) 1999-12-01
CZ290800B6 (cs) 2002-10-16
MD1838G2 (ro) 2002-08-31
AP9600895A0 (en) 1997-01-31
DE69517172D1 (de) 2000-06-29
EP0769017A1 (en) 1997-04-23
JP3225045B2 (ja) 2001-11-05
US20010003744A1 (en) 2001-06-14
BR9508237A (pt) 1999-06-01
US6307043B1 (en) 2001-10-23
SA95160202B1 (ar) 2005-04-16
CN1052010C (zh) 2000-05-03
ZA955644B (en) 1997-01-06
RU2145963C1 (ru) 2000-02-27
FI970032A0 (fi) 1997-01-03
PL181136B1 (pl) 2001-06-29
HRP950382B1 (en) 2000-12-31
US6077832A (en) 2000-06-20
IL114492A0 (en) 1995-11-27
CZ4097A3 (en) 1997-08-13
IS4394A (is) 1996-12-09
SK168896A3 (en) 1997-09-10
JPH10502356A (ja) 1998-03-03
NO970040L (no) 1997-01-29
GR3033744T3 (en) 2000-10-31
IS1812B (is) 2002-05-15
HU227679B1 (en) 2011-11-28
BG63435B1 (bg) 2002-01-31
HU9700034D0 (en) 1997-02-28
HK1003711A1 (en) 1998-11-06
AP736A (en) 1999-03-09
NO308854B1 (no) 2000-11-06
BG101118A (en) 1998-04-30
NO970040D0 (no) 1997-01-06
EP0769017B1 (en) 2000-05-24
TJ270B (en) 2000-08-07
EE9700013A (et) 1997-06-16
AU702248B2 (en) 1999-02-18
AU2805195A (en) 1996-02-09
GEP20002298B (en) 2000-11-25
ATE193298T1 (de) 2000-06-15
CY2249B1 (en) 2003-07-04
PL318062A1 (en) 1997-05-12
UA66744C2 (en) 2004-06-15
RO117699B1 (ro) 2002-06-28
EE03568B1 (et) 2001-12-17
HUT77285A (hu) 1998-03-30
FI970032A (fi) 1997-01-03
YU49443B (sh) 2006-03-03
MX9606732A (es) 1997-04-30
NZ288722A (en) 1998-07-28
PT769017E (pt) 2000-09-29
DK0769017T3 (da) 2000-09-11
US5998605A (en) 1999-12-07
OA10339A (en) 1997-10-07
CN1159194A (zh) 1997-09-10
KR100376075B1 (ko) 2004-02-18
FI117629B (fi) 2006-12-29
SK282046B6 (sk) 2001-10-08

Similar Documents

Publication Publication Date Title
YU45095A (sh) Derivati benzimidazola, postupci za njihovo prirpremanje i primena tih derivata u medicinskoj terapiji, naročito za lečenje ili sprečavanje virusnih infekcija
MEP26208A (en) 4`-supstituted nucleosides
EA200400223A1 (ru) Новые производные 2h-пиридазин-3-она, фармацевтические композиции, содержащие эти производные, и способ получения активного ингредиента
ME00558A (en) Pyrazole derivatives for treating hiv
BR0015193A (pt) Composto, composição farmacêutica, uso de um composto, e, método para tratamento de uma condição associada com trasmissão reduzida de nicotina, para tratamento ou profilaxia de distúrbios psicóticos ou distúrbios de deterioração intelectual e para tratamento ou profilaxia de doenças ou condições humanas
AR041566A1 (es) Derivados de indol utiles para el tratamiento de enfermedades
HUP0301690A2 (hu) Szinergikus eljárások és készítmények rák kezelésére
HUP0400710A2 (hu) Tioéter helyettesítővel helyettesített imidazokinolinszármazékok, alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
NO20073357L (no) 5-karboksamid substituerte tiazol derivater som reagerer med ionekanaler, i saerdeleshet med ionekanaler fra Kv familien
ES2185635T3 (es) Derivados de benzamida y su uso como antagonistas de vasopresina.
ME00017B (me) Derivati kamptotecina koji imaju antitumorno dejstvo
ATE206123T1 (de) Phenylxanthin-derivate
PA8495101A1 (es) Derivados de 13-metileritromicina
BR0015195A (pt) Composto, composição farmacêutica, uso de um composto, e, métodos para o tratamento de uma condição associada com a transmissão reduzida de nicotina para o tratamento ou profilaxia de distúrbios psicóticos ou distúrbios de deterioração intelectual e para o tratamento ou profilaxia de doenças ou condições humanas
NO306345B1 (no) Piperidin-derivater med PAF antagonist-aktivitet, anvendelse derav og farmasöytisk blanding
FR2613365B1 (fr) Nouveaux derives de l'amino tetrahydro-5, 6, 7, 8 naphto (2, 3b) furanne, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
AR007108A1 (es) Agentes antitumorales y antivirales alquilantes, procedimiento para su preparacion, utilizacion de los mismos para la fabricacion de un medicamento y composicion farmaceutica que contiene a dichos agentes.
NO930143D0 (no) Piperidinforbindelser, deres fremstilling og bruk
DE69814473D1 (de) Neue allythiopyridazinderivate und verfahren zu ihrer herstellung
ATE213231T1 (de) Michellamine zur verwendung als antivirale wirkstoffe, zusammensetzung und behandlungsverfahren
DE69330601D1 (de) Serotoninergische ergolin derivate
ES2076838T3 (es) Nuevo derivado de la isoindolinona, su preparacion y las composiciones farmaceuticas que le contienen.
MY159418A (en) New derivatives of flavones, their preparation process, their use as medicaments, pharmaceutical compositions and new use
ES528461A0 (es) Procedimiento de preparacion de nuevos derivados carbamiloxibenzoles
AU2003263455A1 (en) Pyrazole amides for treating hiv infections